US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 0.463
  • -0.006-1.34%
Trading Nov 7 13:41 ET
7.99MMarket Cap-187P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
46.72%-2.34M
12.77%-3.94M
-14.67%-18.07M
-40.89%-5.66M
20.72%-3.51M
-30.23%-4.39M
-14.31%-4.51M
-199.28%-15.76M
-151.11%-4.02M
-44.13%-4.42M
Net income from continuing operations
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
-84.13%-4.29M
Depreciation and amortization
3.81%142.83K
41.37%141.65K
424.05%516.75K
375.08%140.17K
459.56%138.78K
506.18%137.59K
363.86%100.2K
132.18%98.61K
1.78%29.51K
229.16%24.8K
Change In working capital
530.88%1.56M
-2,205.20%-935.21K
-182.69%-1.08M
-312.35%-2.03M
580.57%1.26M
-130.83%-363.12K
107.92%44.42K
179.56%1.31M
-15.36%954.27K
66.12%-262.82K
-Change in receivables
--0
--0
200.00%360.23K
--0
--0
--0
--360.23K
---360.23K
--127.65K
---453.15K
-Change in prepaid assets
-45.25%768.48K
83.29%-112.5K
351.25%362.91K
-3.35%232.64K
67.46%-600.02K
5.18%1.4M
-641.83%-673.21K
92.41%-144.44K
-69.84%240.71K
17.82%-1.84M
-Change in payables and accrued expense
152.10%908.3K
-218.84%-684.49K
-170.29%-1.3M
-442.55%-2.09M
-3.69%1.96M
-1,329.90%-1.74M
184.96%575.98K
-21.23%1.84M
17.45%609.45K
35.64%2.03M
-Change in other current assets
--0
--0
---111.86K
--0
--0
--0
---111.86K
--0
--0
--0
-Change in other current liabilities
-6.88%-112.16K
-4.16%-111.16K
---424.39K
---144.12K
---68.6K
---104.94K
---106.72K
--0
--0
--0
-Change in other working capital
--0
---27.06K
188.63%27.06K
-15.77%-27.25K
---27.44K
----
----
-200.00%-30.53K
87.58%-23.54K
--0
Cash from discontinued investing activities
Operating cash flow
46.72%-2.34M
12.77%-3.94M
-14.67%-18.07M
-40.89%-5.66M
20.72%-3.51M
-30.23%-4.39M
-14.31%-4.51M
-199.28%-15.76M
-151.11%-4.02M
-44.13%-4.42M
Investing cash flow
Cash flow from continuing investing activities
74.84%-4.56K
70.25%-3.84K
64.72%-35.61K
0
-4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
0
Net PPE purchase and sale
74.84%-4.56K
70.25%-3.84K
64.72%-35.61K
--0
---4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
--0
Cash from discontinued investing activities
Investing cash flow
74.84%-4.56K
70.25%-3.84K
64.72%-35.61K
--0
---4.61K
56.94%-18.11K
57.93%-12.9K
59.92%-100.92K
65.89%-28.22K
--0
Financing cash flow
Cash flow from continuing financing activities
-87.65%785.2K
415.56%6.09M
265,542.41%15.91M
333.16%978.15K
3,372.94%7.39M
6.36M
19,614.24%1.18M
-99.98%5.99K
2,280.78%225.82K
-100.88%-225.82K
Net common stock issuance
-87.91%785.2K
415.56%6.09M
--15.91M
--978.15K
--7.26M
--6.5M
--1.18M
--0
--0
--0
Proceeds from stock option exercised by employees
----
----
--0
--0
----
----
----
-79.54%5.99K
--0
--0
Cash from discontinued financing activities
Financing cash flow
-87.65%785.2K
415.56%6.09M
265,542.41%15.91M
333.16%978.15K
3,372.94%7.39M
--6.36M
19,614.24%1.18M
-99.98%5.99K
2,280.78%225.82K
-100.88%-225.82K
Net cash flow
Beginning cash position
202.82%4.91M
-44.30%2.77M
-76.14%4.97M
-15.22%7.45M
-73.42%3.57M
-90.37%1.62M
-76.14%4.97M
2,415.15%20.83M
-60.93%8.79M
16,789.40%13.44M
Current changes in cash
-179.96%-1.56M
164.14%2.15M
86.12%-2.2M
-22.58%-4.69M
183.49%3.88M
157.11%1.95M
15.79%-3.35M
-179.30%-15.86M
-128.32%-3.82M
-120.73%-4.65M
End cash Position
-6.10%3.35M
202.82%4.91M
-44.30%2.77M
-44.30%2.77M
-15.22%7.45M
-73.42%3.57M
-90.37%1.62M
-76.14%4.97M
-76.14%4.97M
-60.93%8.79M
Free cash flow
46.84%-2.34M
12.93%-3.94M
-14.16%-18.11M
-39.91%-5.66M
20.62%-3.51M
-29.16%-4.41M
-13.75%-4.53M
-187.29%-15.86M
-140.02%-4.05M
-40.85%-4.42M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 46.72%-2.34M12.77%-3.94M-14.67%-18.07M-40.89%-5.66M20.72%-3.51M-30.23%-4.39M-14.31%-4.51M-199.28%-15.76M-151.11%-4.02M-44.13%-4.42M
Net income from continuing operations -19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M-84.13%-4.29M
Depreciation and amortization 3.81%142.83K41.37%141.65K424.05%516.75K375.08%140.17K459.56%138.78K506.18%137.59K363.86%100.2K132.18%98.61K1.78%29.51K229.16%24.8K
Change In working capital 530.88%1.56M-2,205.20%-935.21K-182.69%-1.08M-312.35%-2.03M580.57%1.26M-130.83%-363.12K107.92%44.42K179.56%1.31M-15.36%954.27K66.12%-262.82K
-Change in receivables --0--0200.00%360.23K--0--0--0--360.23K---360.23K--127.65K---453.15K
-Change in prepaid assets -45.25%768.48K83.29%-112.5K351.25%362.91K-3.35%232.64K67.46%-600.02K5.18%1.4M-641.83%-673.21K92.41%-144.44K-69.84%240.71K17.82%-1.84M
-Change in payables and accrued expense 152.10%908.3K-218.84%-684.49K-170.29%-1.3M-442.55%-2.09M-3.69%1.96M-1,329.90%-1.74M184.96%575.98K-21.23%1.84M17.45%609.45K35.64%2.03M
-Change in other current assets --0--0---111.86K--0--0--0---111.86K--0--0--0
-Change in other current liabilities -6.88%-112.16K-4.16%-111.16K---424.39K---144.12K---68.6K---104.94K---106.72K--0--0--0
-Change in other working capital --0---27.06K188.63%27.06K-15.77%-27.25K---27.44K---------200.00%-30.53K87.58%-23.54K--0
Cash from discontinued investing activities
Operating cash flow 46.72%-2.34M12.77%-3.94M-14.67%-18.07M-40.89%-5.66M20.72%-3.51M-30.23%-4.39M-14.31%-4.51M-199.28%-15.76M-151.11%-4.02M-44.13%-4.42M
Investing cash flow
Cash flow from continuing investing activities 74.84%-4.56K70.25%-3.84K64.72%-35.61K0-4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K0
Net PPE purchase and sale 74.84%-4.56K70.25%-3.84K64.72%-35.61K--0---4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K--0
Cash from discontinued investing activities
Investing cash flow 74.84%-4.56K70.25%-3.84K64.72%-35.61K--0---4.61K56.94%-18.11K57.93%-12.9K59.92%-100.92K65.89%-28.22K--0
Financing cash flow
Cash flow from continuing financing activities -87.65%785.2K415.56%6.09M265,542.41%15.91M333.16%978.15K3,372.94%7.39M6.36M19,614.24%1.18M-99.98%5.99K2,280.78%225.82K-100.88%-225.82K
Net common stock issuance -87.91%785.2K415.56%6.09M--15.91M--978.15K--7.26M--6.5M--1.18M--0--0--0
Proceeds from stock option exercised by employees ----------0--0-------------79.54%5.99K--0--0
Cash from discontinued financing activities
Financing cash flow -87.65%785.2K415.56%6.09M265,542.41%15.91M333.16%978.15K3,372.94%7.39M--6.36M19,614.24%1.18M-99.98%5.99K2,280.78%225.82K-100.88%-225.82K
Net cash flow
Beginning cash position 202.82%4.91M-44.30%2.77M-76.14%4.97M-15.22%7.45M-73.42%3.57M-90.37%1.62M-76.14%4.97M2,415.15%20.83M-60.93%8.79M16,789.40%13.44M
Current changes in cash -179.96%-1.56M164.14%2.15M86.12%-2.2M-22.58%-4.69M183.49%3.88M157.11%1.95M15.79%-3.35M-179.30%-15.86M-128.32%-3.82M-120.73%-4.65M
End cash Position -6.10%3.35M202.82%4.91M-44.30%2.77M-44.30%2.77M-15.22%7.45M-73.42%3.57M-90.37%1.62M-76.14%4.97M-76.14%4.97M-60.93%8.79M
Free cash flow 46.84%-2.34M12.93%-3.94M-14.16%-18.11M-39.91%-5.66M20.62%-3.51M-29.16%-4.41M-13.75%-4.53M-187.29%-15.86M-140.02%-4.05M-40.85%-4.42M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data